Report on the 1999 financial year

Report on the 1999 financial year (Göteborg, 9 February 2000) The Nobel Biocare Group * Operating income increased by 91% compared with operating income before non-recurring items in 1998 and amounted to SEK 232.6 million (121.5). * Sales increased by 33% to total SEK 1,738.1 million (1,309.7). * Dental Implant sales improved by 31% to total SEK 1,528.4 million (1,170.2). * Sales within Procera® increased by 50% and totalled SEK 209.7 million (139.5). * Earnings per share excluding goodwill amortization and non-recurring items increased by 87% to SEK 8.39 (4.49). * The Board of Directors proposes that the dividend should be increased to SEK 2.00 per share (1.70). SEK M 1999 1998 Change Net turnover 1 738.1 1 309.7 +32.7% of which Dental Implants 1 528.4 1 170.2 +30.6% ® of which Procera 209.7 139.5 +50.3% Operating income excluding non-recurring 232.6 121.5 +91.4% items Non-recurring items - -47.7 Operating income 232.6 73.8 +215.2% Income after net financial items 197.9 64.7 +205.9% Earnings per share, SEK 6.21 1.88 +230.3% Earnings per share excluding goodwill amortization and non-recurring items, SEK 8.39 4.49 +86.9% 1998 includes four months of Steri-Oss' operations ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/02/09/20000209BIT00540/bit0001.doc http://www.bit.se/bitonline/2000/02/09/20000209BIT00540/bit0002.pdf